Latest Campaign Updates

MEPs call for faster implementation of clinical trial regulation

The Group of the Progressive Alliance of Socialists and Democrats (the S&D Group) is today calling on the European Commission to speed up implementation of the new European Clinical Trial Regulation. The S&D Group is the second largest political group in the European Parliament with 190 members from all 28 EU member states.

The call follows the recent […]

2nd February 2016|

Wellcome Trust appoints new independent review panel for clinical data sharing website

The Wellcome Trust has appointed a new independent review panel to assess applications from researchers for access to clinical trial data through the website

The website was set up by GlaxoSmithKline (GSK) in May 2013 to allow researchers to request trial data to carry out further research. Since then 12 more pharmaceutical companies have also committed to […]

26th January 2016|

British Pharmacological Society calls for transparency early in clinical research

Today, the British Pharmacological Society (BPS) has released a statement calling for greater trial transparency in the testing of new medicines. Following the recent phase 1 clinical trial catastrophe in France, the BPS recommends “release of the study design and protocol, the full Investigation Medicinal Product Dossier (IMPD) and the batch release data for such studies, […]

22nd January 2016|

International Committee of Medical Journal Editors proposes individual patient data sharing

The International Committee of Medical Journal Editors (ICMJE) is proposing that authors must share the anonymised individual patient data (IPD) underlying clinical trial results published in its member journals.

On January 20th 2016 the ICMJE published an editorial in 14 major medical journals sharing their proposal, and are inviting feedback until April 18th 2016.

The ICMJE also […]

21st January 2016|

Clinical trial participants speak out over missing trial results

In the past week, The New York Times and The Atlantic have both published incredibly moving pieces written by clinical trial participants. Each patient has their own journey and experience, but both have something in common; a sense of outrage and betrayal over the systematic failing to register trials and report results.

AllTrials is a campaign to get all clinical […]

19th January 2016|

Comment from Ben Goldacre on the phase 1 clinical trial disaster in France

It is being reported that one person has been left in a coma and five others are in a critical condition in hospital after taking part in a phase 1 drug trial in France.

Phase 1 clinical trials test new drugs in healthy volunteers to evaluate their safety. In 2006 in the UK six people were […]

15th January 2016|

Why AllTrials matters to vets

AllTrials is a campaign to get all clinical trials registered and their results reported. Even though AllTrials is focused on clinical trials in human medicine, the success of the campaign is important to vets too, who do not even have a clinical trial registry.

An international group of interested organisations and individuals within the veterinary profession are […]

23rd December 2015|

Enacting Pharmaceutical Transparency – Who, What, How, When & Why

In this guest piece, Matthew Herder shares a template letter that physicians, researchers, civil society groups, investigative journalists and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.
This is a call to action—a call that physicians, biomedical researchers, civil society, journalists and others have long made concerning the need to improve […]

21st December 2015|

Using AllTrials to teach the importance of trial transparency

AllTrials will be a centrepiece of a new online course taught by the University of Miami called Health Information Exchange. Students of this course, aimed at nurses and medical professionals, will learn why clinical trial transparency is so important to researchers and physicians. This course is part of a new Online Health Informatics, Nursing Informatics and Certificate […]

11th December 2015|

European Medicines Agency prioritises transparency

Clinical trial transparency is a key priority of the new Executive Director of the European Medicines Agency (EMA), Professor Guido Rasi.

In a press briefing on Wednesday 9th December Professor Rasi outlined his vision for his five-year mandate as Executive Director. He highlighted transparency as a key aspect of the EMA’s approach moving forward.

On the EMA’s commitment to transparency, […]

11th December 2015|